H. Corvol, C. A. Hodges, M. L. Drumm, and L. Guillot, Moving beyond genetics: is FAM13A a major biological contributor in lung physiology and chronic lung diseases, J Med Genet, vol.51, issue.10, pp.646-655, 2014.

D. B. Hancock, M. Eijgelsheim, J. B. Wilk, S. A. Gharib, L. R. Loehr et al., Meta-analyses of genome-wide association studies identify multiple loci associated with pulmonary function, Nat Genet, vol.42, issue.1, pp.45-52, 2010.

I. Ziolkowska-suchanek, M. Mosor, P. Gabryel, M. Grabicki, M. Zurawek et al., Susceptibility loci in lung cancer and COPD: association of IREB2 and FAM13A with pulmonary diseases, Sci Rep, vol.5, p.13502, 2015.

R. P. Young, R. J. Hopkins, B. A. Hay, C. F. Whittington, M. J. Epton et al., FAM13A locus in COPD is independently associated with lung cancerevidence of a molecular genetic link between COPD and lung cancer, Appl Clin Genet, vol.4, pp.1-10, 2011.

M. H. Cho, N. Boutaoui, B. J. Klanderman, J. S. Sylvia, J. P. Ziniti et al., Variants in FAM13A are associated with chronic obstructive pulmonary disease, Nat Genet, vol.42, issue.3, pp.200-202, 2010.

H. Corvol, N. Rousselet, K. E. Thompson, L. Berdah, G. Cottin et al., FAM13A is a modifier gene of cystic fibrosis lung phenotype regulating rhoa activity, actin cytoskeleton dynamics and epithelialmesenchymal transition, J Cyst Fibros, vol.17, issue.2, pp.190-203, 2018.
URL : https://hal.archives-ouvertes.fr/hal-01788583

B. D. Hobbs, K. De-jong, M. Lamontagne, Y. Bosse, N. Shrine et al., Genetic loci associated with chronic obstructive pulmonary disease overlap with loci for lung function and pulmonary fibrosis, Nat Genet, vol.49, issue.3, pp.426-458, 2017.

C. Van-moorsel, Trade-offs in aging lung diseases: a review on shared but opposite genetic risk variants in idiopathic pulmonary fibrosis, lung cancer and chronic obstructive pulmonary disease, Curr Opin Pulm Med, vol.24, issue.3, pp.309-326, 2018.

Z. Jin, J. W. Chung, W. Mei, S. Strack, C. He et al., Regulation of nuclear-cytoplasmic shuttling and function of Family with sequence similarity 13, member A (Fam13a), by B56-containing PP2As and Akt, Mol Biol Cell, vol.26, issue.6, pp.1160-73, 2015.

Z. Jiang, T. Lao, W. Qiu, F. Polverino, K. Gupta et al., A chronic obstructive pulmonary disease susceptibility gene, FAM13A, regulates protein stability of beta-catenin, Am J Respir Crit Care Med, vol.194, issue.2, pp.185-97, 2016.

F. Eisenhut, L. Heim, S. Trump, S. Mittler, N. Sopel et al., FAM13A is associated with non-small cell lung cancer (NSCLC) progression and controls tumor cell proliferation and survival, Oncoimmunology, vol.6, issue.1, p.1256526, 2017.

P. Pascual-vargas, S. Cooper, J. Sero, V. Bousgouni, M. Arias-garcia et al., RNAi screens for Rho GTPase regulators of cell shape and YAP/TAZ localisation in triple, negative breast cancer. Sci Data, vol.4, p.170018, 2017.

A. B. Vojtek and S. M. Hollenberg, Ras-Raf interaction: two-hybrid analysis, Methods Enzymol, vol.255, pp.331-373, 1995.

P. L. Bartel and S. Fields, Analyzing protein-protein interactions using twohybrid system, Methods Enzymol, vol.254, pp.241-63, 1995.

M. Fromont-racine, J. C. Rain, and P. Legrain, Toward a functional analysis of the yeast genome through exhaustive two-hybrid screens, Nat Genet, vol.16, issue.3, pp.277-82, 1997.

E. Formstecher, S. Aresta, V. Collura, A. Hamburger, A. Meil et al., Protein interaction mapping: a Drosophila case study, Genome Res, vol.15, issue.3, pp.376-84, 2005.
URL : https://hal.archives-ouvertes.fr/hal-00118429

J. Wojcik, I. G. Boneca, and P. Legrain, Prediction, assessment and validation of protein interaction maps in bacteria, J Mol Biol, vol.323, issue.4, pp.763-70, 2002.

J. C. Rain, L. Selig, H. De-reuse, V. Battaglia, C. Reverdy et al., The protein-protein interaction map of Helicobacter pylori, Nature, vol.409, issue.6817, pp.211-216, 2001.

H. Mi, A. Muruganujan, X. Huang, D. Ebert, C. Mills et al., Protocol update for large-scale genome and gene function analysis with the PANTHER classification system (v.14.0), Nat Protoc, vol.14, issue.3, pp.703-724, 2019.

G. C. Meacham, Z. Lu, S. King, E. Sorscher, A. Tousson et al., The Hdj-2/ Hsc70 chaperone pair facilitates early steps in CFTR biogenesis, EMBO J, vol.18, issue.6, pp.1492-505, 1999.

A. Holownia, R. M. Mroz, A. Kielek, E. Chyczewska, and J. J. Braszko, Nuclear HSP90 and HSP70 in COPD patients treated with formoterol or formoterol and corticosteroids, Eur J Med Res, vol.14, issue.4, pp.104-111, 2009.

U. Baumgartner, F. Berger, A. Hashemi-gheinani, and S. S. Burgener, Monastyrskaya K, Vassella E. miR-19b enhances proliferation and apoptosis resistance via the EGFR signaling pathway by targeting PP2A and BIM in non-small cell lung cancer, Mol Cancer, vol.17, issue.1, p.44, 2018.

R. Yang, L. Yang, F. Qiu, L. Zhang, H. Wang et al., Functional genetic polymorphisms in PP2A subunit genes confer increased risks of lung cancer in southern and eastern Chinese, PLoS ONE, vol.8, issue.10, p.77285, 2013.

S. T. Uh, S. M. Koo, A. S. Jang, S. W. Park, J. S. Choi et al., Proteomic differences with and without ozone-exposure in a smoking-induced emphysema lung model, Korean J Intern Med, vol.30, issue.1, pp.62-72, 2015.

G. T. Noutsios, P. Silveyra, F. Bhatti, and J. Floros, Exon B of human surfactant protein A2 mRNA, alone or within its surrounding sequences, interacts with 14-3-3; role of cis-elements and secondary structure, Am J Physiol Lung Cell Mol Physiol, vol.304, issue.11, pp.722-757, 2013.

A. Okayama, Y. Miyagi, F. Oshita, M. Nishi, Y. Nakamura et al., Proteomic analysis of proteins related to prognosis of lung adenocarcinoma, J Proteome Res, vol.13, issue.11, pp.4686-94, 2014.

X. Cao, Y. Z. Chen, R. Z. Luo, L. Zhang, S. L. Zhang et al., Tyrosineprotein phosphatase non-receptor type 12 expression is a good prognostic factor in resectable non-small cell lung cancer, Oncotarget, vol.6, issue.13, pp.11704-11717, 2015.

F. Jiang, Q. Qiu, A. Khanna, N. W. Todd, J. Deepak et al., Aldehyde dehydrogenase 1 is a tumor stem cell-associated marker in lung cancer, Mol Cancer Res, vol.7, issue.3, pp.330-338, 2009.

Y. W. Koh, J. H. Han, S. Haam, and J. Jung, ALDH1 expression correlates with an epithelial-like phenotype and favorable prognosis in lung adenocarcinoma: a study based on immunohistochemistry and mRNA expression data, J Cancer Res Clin Oncol, vol.145, issue.6, pp.1427-1463, 2019.

S. Stepaniants, I. M. Wang, Y. Boie, J. Mortimer, B. Kennedy et al., Genes related to emphysema are enriched for ubiquitination pathways, BMC Pulm Med, vol.14, p.187, 2014.

X. N. Gan, T. Q. Gan, R. Q. He, J. Luo, R. X. Tang et al., Clinical significance of high expression of miR-452-5p in lung squamous cell carcinoma, Oncol Lett, vol.15, issue.5, pp.6418-6448, 2018.

J. J. Chen, K. Peck, T. M. Hong, S. C. Yang, Y. P. Sher et al., Global analysis of gene expression in invasion by a lung cancer model, Cancer Res, vol.61, issue.13, pp.5223-5253, 2001.

T. Fan, R. Li, N. W. Todd, Q. Qiu, H. B. Fang et al., Up-regulation of 14-3-3zeta in lung cancer and its implication as prognostic and therapeutic target, Cancer Res, vol.67, issue.16, pp.7901-7907, 2007.

X. D. Liu, D. F. Xie, Y. L. Wang, H. Guan, R. X. Huang et al., Integrated analysis of lncRNA-mRNA co-expression networks in the alpha-particle induced carcinogenesis of human branchial epithelial cells, Int J Radiat Biol, vol.95, issue.2, pp.144-55, 2019.

M. Li, H. Lu, X. Liu, Q. Meng, Y. Zhao et al., Overexpression of 14-3-3zeta in lung tissue predicts an improved outcome in patients with lung adenocarcinoma, Oncol Lett, vol.16, issue.1, pp.1051-1059, 2018.

H. A. Berger, S. M. Travis, and M. J. Welsh, Regulation of the cystic fibrosis transmembrane conductance regulator Cl-channel by specific protein kinases and protein phosphatases, J Biol Chem, vol.268, issue.3, pp.2037-2084, 1993.

D. F. Doherty, S. Nath, J. Poon, R. F. Foronjy, M. Ohlmeyer et al., Protein phosphatase 2A reduces cigarette smoke-induced cathepsin S and Loss of Lung Function, Am J Respir Crit Care Med, vol.200, issue.1, pp.51-62, 2019.

R. Tohme, S. Izadmehr, S. Gandhe, G. Tabaro, S. Vallabhaneni et al., Direct activation of PP2A for the treatment of tyrosine kinase inhibitorresistant lung adenocarcinoma. JCI Insight, 2019.

A. Khorrami, S. Bagheri, M. Tavallaei, M. Gharechahi, and J. , The functional significance of 14-3-3 proteins in cancer: focus on lung cancer, Horm Mol Biol Clin Investig, 2017.

Y. Wang, P. J. Kuan, C. Xing, J. T. Cronkhite, F. Torres et al., Genetic defects in surfactant protein A2 are associated with pulmonary fibrosis and lung cancer, Am J Hum Genet, vol.84, issue.1, pp.52-61, 2009.

S. Orchard, M. Ammari, B. Aranda, L. Breuza, L. Briganti et al., The MIntAct project-IntAct as a common curation platform for 11 molecular interaction databases, Nucleic Acids Res, vol.42, pp.358-63, 2014.

, Publisher's Note

, Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations